AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Eckert & Ziegler Strahlen- und Medizintechnik AG

Share Issue/Capital Change Jan 12, 2009

130_rns_2009-01-12_2191ce80-57f2-4308-aa66-e2ab34269413.html

Share Issue/Capital Change

Open in Viewer

Opens in native device viewer

News Details

Ad-hoc | 12 January 2009 12:44

Eckert & Ziegler resolves capital increase

ECKERT & ZIEGLER Strahlen- und Medizintechnik AG / Capital Increase

Release of an Ad hoc announcement according to § 15 WpHG, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.


Berlin, 12th January 2009. – The Board of Directors at Eckert & Ziegler
Strahlen- und Medizintechnik AG (ISIN DE 0005659700) has resolved today
with the consent of the Supervisory Board to implement a capital increase
for cash with a partial utilisation of the approved capital in volumes of
up to 628,633 new shares. With the expected funds inflow parts of the
purchase price and the net current assets are to be financed in connection
with the acquisition of a competitor. As announced on 22 December 2008
Eckert & Ziegler acquired the buyer’s option.

The shareholders of the company will be granted a purchase right. Trading
the purchase rights via the stock exchange is not possible. The new shares
will not be permitted to be traded on the regulated market until further
notice so that no stock market trading will take place. The company intends
to effect the listing of the new shares at a later date. Linked to this is
the prior establishment and approval of a securities prospectus according
to the regulations of the Securities Prospectus Act. BankM, representation
of biw Bank für Investments und Wertpapiere AG, has been commissioned with
monitoring the capital increase.


Information and Explaination of the Issuer to this News:

An interview with the Chairman of the Board, Dr. Andreas Eckert, on the
topic of capital increase will be published at www.ezag.de.

Eckert & Ziegler AG, Karolin Riehle, Investor Relations
Robert-Rössle-Str. 10, D-13125 Berlin
Tel.: +49 (0) 30 / 94 10 84-138, Fax –112
E-Mail: [email protected], www.ezag.de

12.01.2009 Financial News transmitted by DGAP

Language: English
Issuer: ECKERT & ZIEGLER Strahlen- und Medizintechnik AG
Robert-Rössle-Str. 10
13125 Berlin
Deutschland
Phone: +49 (0)30 941 084-0
Fax: +49 (0)30 941 084-112
E-mail: [email protected]
Internet: www.ezag.de
ISIN: DE0005659700
WKN: 565970
Listed: Regulierter Markt in Frankfurt (Prime Standard), Stuttgart;
Freiverkehr in Berlin, München, Hamburg, Düsseldorf

End of News DGAP News-Service


Talk to a Data Expert

Have a question? We'll get back to you promptly.